Steven L. Hoerter
Overview
Steven L. Hoerter received an average of $9M in total compensation, including $592K in salary, at Deciphera Pharmaceuticals from 2019 to 2021. Steven Hoerter also received an average of $2M at Clovis Oncology from 2011 to 2015.
- 2021
- 2020
- 2019
- 2015
- 2014
- 2013
- 2012
- 2011
Deciphera PharmaceuticalsPresident and Chief Executive Officer
Deciphera PharmaceuticalsPresident and Chief Executive Officer
Deciphera PharmaceuticalsPresident and Chief Executive Officer
Clovis OncologyEVP and Chief Commercial Officer
Clovis OncologyEVP and Chief Commercial Officer
Clovis OncologyEVP and Chief Commercial Officer
Clovis OncologyEVP and Chief Commercial Officer
Clovis OncologySenior Vice President of Commercial
Source: SEC filings on April 26, 2022, April 24, 2020, April 27, 2016, April 30, 2015, and April 30, 2014.
Related executives
We found 14 more executives who work or worked at Deciphera Pharmaceuticals and Clovis Oncology.
Matthew Sherman
Deciphera Pharmaceuticals
Chief Medical Officer
Daniel Flynn
Deciphera Pharmaceuticals
Chief Scientific Officer
Thomas Kelly
Deciphera Pharmaceuticals
Chief Financial Officer
Daniel Martin
Deciphera Pharmaceuticals
Chief Commercial Officer
Patrick Mahaffy
Clovis Oncology
Chief Executive Officer
Lindsey Rolfe
Clovis Oncology
Chief Medical Officer
Gillian Ivers-Read
Clovis Oncology
EVP and Chief Regulatory Officer
Paul Gross
Clovis Oncology